Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Peptides Interacting with Growth Factor Receptors Regulating Angiogenesis

Chapter
Publication Date:
2016
abstract:
Angiogenesis regulation strictly depends on the balance between pro- and anti-angiogenic molecules such as growth factors. Growth factors exert their biological action selectively binding to and activating specific cell membrane receptors which then transfer the message to cell interior triggering specific biochemical pathways ending in the angiogenic response. Molecules able to interfere with the molecular recognition between an angiogenic growth factor and its receptor can modulate the angiogenesis. Peptides are good candidates to develop new lead compounds able to target the growth factor-receptor protein interface for pharmacological applications. In this review we describe peptides targeting the receptors of the pro-angiogenic growth factors Fibroblast Growth Factor, Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor. The biological function and the three-dimensional structure of each growth factor/receptor system are discussed, as well as the molecular interaction between peptides and the receptors. Finally, we highlight the pharmacological and diagnostic applications of these peptides in angiogenesis related diseases
Iris type:
02.01 Contributo in volume (Capitolo o Saggio)
Keywords:
peptide; angiogenesis; TRK
List of contributors:
D'Andrea, LUCA DOMENICO; DI STASI, Rossella; DE ROSA, Lucia
Authors of the University:
D'ANDREA LUCA DOMENICO
DE ROSA LUCIA
DI STASI ROSSELLA
Handle:
https://iris.cnr.it/handle/20.500.14243/316308
Book title:
Frontiers in medicinal chemistry
Published in:
FRONTIERS IN MEDICINAL CHEMISTRY
Series
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)